Children between seven and 12 years of age had a higher risk of having anti-CSP antibodies or an infection than younger children (OR = 2.60; 95%CI: 2.0–3.35 for anti-CSP antibodies and OR = 1.90; 95%CI: 1.58–2.28 for the prevalence of infection). Here, DNAJC5 is linked to infection.